Transcranial Doppler in Mild and Moderate Traumatic Brain Injury (TBI)
NCT ID: NCT05151978
Last Updated: 2021-12-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
105 participants
OBSERVATIONAL
2021-06-03
2022-02-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
(glasgow coma scale) 9 _15
No Secondary Neurological deterioration
Transcranial Doppler
Transcranial Doppler on middle cerebral arteries
(glasgow coma scale) 9_15
Secondary Neurological deterioration
Transcranial Doppler
Transcranial Doppler on middle cerebral arteries
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Transcranial Doppler
Transcranial Doppler on middle cerebral arteries
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
25 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Tanta University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Mai Kamal
Tanta elnady street elgharbia
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ahmed Goneim
Role: STUDY_CHAIR
Head of faculty of medicine
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine
Tanta, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
aymen elghamry
Role: primary
hala elgendy
Role: backup
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Related Links
Access external resources that provide additional context or updates about the study.
https://pubmed.ncbi.nlm.nih.gov/31497078/
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
33574/12/19
Identifier Type: -
Identifier Source: org_study_id